Hadasit Bio Holding Ltd.
Funds and develops early-stage biotech companies, commercializing medical university research.
HDST-M | TA
Overview
Corporate Details
- ISIN(s):
- IL0010954050
- LEI:
- Country:
- Israel
- Address:
- Jerusaelm Bio-Park, 5th Floor, Hadassah Ein-Kerem Campus, 91120 Jerusalem
- Website:
- https://hadasit.org.il
- Sector:
- Financial and insurance activities
- Industry:
- Other financial service activities, except insurance and pension funding activities
Description
Hadasit Bio Holding Ltd. is a publicly traded investment company and a subsidiary of Hadasit Ltd., the technology transfer and innovation arm of the Hadassah University Medical Center. The company focuses on identifying, funding, and developing a portfolio of early-stage biotechnology and medical technology companies. Its primary mission is to commercialize promising intellectual property and scientific research originating from the Hadassah ecosystem. Hadasit Bio Holding provides strategic investment and guidance to its portfolio companies, helping them advance through critical development milestones such as Phase I and II clinical trials. By creating synergies between academia, medicine, and industry, the company aims to translate groundbreaking medical innovations into marketable healthcare products and therapies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-05-05 18:35 |
Regulatory News Service
The company has become a "shell company", the sector classification of the comp…
|
Hebrew (modern) | 131.7 KB | ||
| 2023-09-28 19:39 |
Regulatory News Service
HADASIT BIO-M – Discontinuation of Market Making
|
Hebrew (modern) | 123.1 KB | ||
| 2023-01-15 17:37 |
Regulatory News Service
Non-Comliance with the Maintaenance Rules Based on Data as of December 31,2022 …
|
Hebrew (modern) | 132.9 KB | ||
| 2020-12-03 16:10 |
Foreign Filer Report
Reports Positive Interim Results From Phase II Clinical Trial Evaluating Alloce…
|
English | 169.5 KB | ||
| 2020-12-03 16:10 |
Foreign Filer Report
Reports Positive Interim Results From Phase II Clinical Trial Evaluating Alloce…
|
English | 35.9 KB |
Automate Your Workflow. Get a real-time feed of all Hadasit Bio Holding Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Hadasit Bio Holding Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
